Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Devi Nair , Vivek Reddy Added: 2 weeks ago
ACC.26 - At ACC.26 in New Orleans, Dr Devi Nair (Arkansas, US) and Dr Vivek Reddy (New York, US) dissect the late-breaking CHAMPION‑AF trial, a large randomized comparison of first-line left atrial appendage closure with WATCHMAN FLX versus continued NOAC therapy in patients with non-valvular AF who can tolerate anticoagulation. They review the trial design, post‑implant antithrombotic and… View more
Author(s): Francesco Santoro Added: 1 week ago
EHRA 2026 — Dr Francesco Santoro joins us to discuss findings from his meta-analysis of randomised controlled trials comparing catheter ablation with anti-arrhythmic drug therapy in patients with ventricular tachycardia and ischaemic heart disease.This meta-analysis pooled data from four RCTs enrolling 947 patients with ischaemic heart disease and ICD implantation, randomised to either catheter… View more
Author(s): Thorsten Hanke Added: 1 year ago
First presented at ESC 2024, this on-demand programme sees Prof Gregory Lip(University of Liverpool, UK) lead a faculty comprisingProf Elena Arbelo (University of Barcelona, ES), ProfThorsten Hanke(Asklepios Klinikum Harburg, DE) andProf Richard Whitlock(McMaster University, CA) review the application of the latest AF guidance in a clinical setting.This case-based programme explores the… View more
Start date: Sep 01, 2024 End date: Sep 01, 2024
Radcliffe Medical Education is hosting a symposium entitled 'AF Stroke Prevention: Applying New Guidance in the Real World' at 15:15 UTC+1 on Sunday 1 September 2024 in Dublin Room atESC 2024, ExCel Centre, London, UK.Add to your calendar.OverviewProf Gregory Lip(University of Liverpool, Liverpool, UK) will lead a faculty comprisingProf Elena Arbelo (University of Barcelona, ES), ProfThorsten… View more
Added: 1 month ago Source:  Radcliffe CVRM
Renin-independent aldosteronism is a common and often underrecognised condition. A new analysis from the Atherosclerosis Risk in Communities (ARIC) study has investigated whether this broader spectrum of aldosteronism is associated with incident cardiovascular disease (CVD) in older, community-dwelling adults.¹MethodologyThis prospective cohort analysis included 3,477 participants from the ARIC… View more
Author(s): Vivek Reddy Added: 2 months ago
Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, NY, US) joins us to discuss evolving strategies for stroke management following atrial fibrillation ablation, addressing the critical question of when anticoagulation can be safely discontinued after successful ablation.Interview Questions:There's been a lot of talk about optimal anticoagulation – what's the headline? In which… View more
Added: 8 months ago Source:  Radcliffe Cardiology
The decision to switch frail, elderly patients with atrial fibrillation (AF) from a stable vitamin K antagonist (VKA) regimen to a direct-acting oral anticoagulant (DOAC) remains a subject of clinical debate. A new substudy from the COMBINE-AF dataset provides clarity, suggesting that while the switch reduces severe outcomes like stroke and death, it does not lower the risk of major bleeding and… View more
Author(s): Valentina Kutyifa Added: 11 months ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of… View more